Successful mycophenolate mofetil treatment of a patient with severe steroid-refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancer.
Ginji OmoriKohichi TakadaKazuyuki MuraseNaotaka HayasakaHajime NakamuraSatoshi IyamaHiroyuki OhnumaKoji MiyanishiFumimasa FukutaToshiaki TanakaNaoya MasumoriJunji KatoPublished in: Clinical case reports (2020)
Mycophenolate mofetil resulted in rapid improvement of steroid-refractory immune-related adverse event hepatitis, induced by nivolumab plus ipilimumab.